MRNA insider trading
NasdaqGS HealthcareModerna, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Moderna, Inc.
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax , mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Company website: www.modernatx.com
MRNA insider activity at a glance
FilingIQ has scored 3,901 insider transactions for MRNA since Nov 15, 2016. The most recent filing in our index is dated May 6, 2026.
Across the full history, 8 open-market purchases
and 2,790 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MRNA insider trades is 59.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding MRNA
Frequently asked
- How many insider trades does FilingIQ track for MRNA?
- FilingIQ tracks 3,901 Form 4 insider transactions for MRNA (Moderna, Inc.), covering filings from Nov 15, 2016 onwards. 80 of those were filed in the last 90 days.
- Are MRNA insiders net buyers or net sellers?
- Across the full Form 4 history for MRNA, 8 transactions (0%) were open-market purchases and 2,790 (72%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MRNA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MRNA in?
- Moderna, Inc. (MRNA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $19.71B.
Methodology & sources
Every MRNA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.